ELIMINATION OF SOLUBLE I-123 LABELED AGGREGATES OF IGG IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - EFFECT OF SERUM IGG AND NUMBERS OF ERYTHROCYTE COMPLEMENT RECEPTOR TYPE-1

被引:19
作者
HALMA, C
BREEDVELD, FC
DAHA, MR
BLOK, D
EVERSSCHOUTEN, JH
HERMANS, J
PAUWELS, EKJ
VANES, LA
机构
[1] UNIV HOSP LEIDEN,DEPT RHEUMATOL,2300 RC LEIDEN,NETHERLANDS
[2] UNIV HOSP LEIDEN,DEPT CLIN PHARMACOL & TOXICOL,2300 RC LEIDEN,NETHERLANDS
[3] UNIV HOSP LEIDEN,DEPT MED STAT,2300 RC LEIDEN,NETHERLANDS
[4] UNIV HOSP LEIDEN,DEPT DIAGNOST RADIOL,DIV NUCL MED,2300 RC LEIDEN,NETHERLANDS
来源
ARTHRITIS AND RHEUMATISM | 1991年 / 34卷 / 04期
关键词
D O I
10.1002/art.1780340409
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using soluble I-123-labeled aggregates of human IgG (I-123-AHIgG) as a probe, we examined the function of the mononuclear phagocyte system in 22 patients with systemic lupus erythematosus (SLE) and 12 healthy controls. In SLE patients, a decreased number of erythrocyte complement receptor type 1 was associated with less binding of I-123-AHIgG to erythrocytes and a faster initial rate of elimination of I-123-AHIgG (mean +/- SEM half-maximal clearance time 5.23 +/- 0.2 minutes, versus 6.58 +/- 0.2 minutes in the controls), with possible spillover of the material outside the mononuclear phagocyte system of the liver and spleen. However, multiple regression analysis showed that serum concentrations of IgG were the most important factor predicting the rate of I-123-AHIgG elimination. IgG concentration may thus reflect immune complex clearance, which in turn, would influence the inflammatory reaction, in SLE.
引用
收藏
页码:442 / 452
页数:11
相关论文
共 41 条
[1]   IMMUNOLOGY OF DNA .3. CRITHIDIA-LUCILIAE, A SIMPLE SUBSTRATE FOR DETERMINATION OF ANTI-DSDNA WITH IMMUNOFLUORESCENCE TECHNIQUE [J].
AARDEN, LA ;
DEGROOT, ER ;
FELTKAMP, TEW .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 254 :505-515
[2]   SERUM IMMUNOGLOBULINS IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALARCONS.D ;
FISHBEIN, E .
CLINICAL SCIENCE, 1972, 43 (01) :121-&
[3]  
AREND WP, 1971, J IMMUNOL, V107, P63
[4]   IN-VITRO ADHERENCE OF SOLUBLE IMMUNE COMPLEXES TO MACROPHAGES [J].
AREND, WP ;
MANNIK, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (03) :514-&
[5]   FC-SPECIFIC RETICULOENDOTHELIAL CLEARANCE IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND GLOMERULONEPHRITIS [J].
BANNISTER, KM ;
HAY, J ;
CLARKSON, AR ;
WOODROFFE, AJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1984, 3 (04) :287-292
[6]   INCREASED IMMUNOGLOBULIN-SECRETING CELLS IN THE BLOOD OF PATIENTS WITH ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BLAESE, RM ;
GRAYSON, J ;
STEINBERG, AD .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (03) :345-350
[7]   IMMUNOGLOBULINS G A AND M IN SYSTEMIC LUPUS ERYTHEMATOSUS - RELATIONSHIP TO SERUM COMPLEMENT TITER LATEX TITER ANTINUCLEAR ANTIBODY AND MANIFESTATIONS OF CLINICAL DISEASE [J].
CASS, RM ;
MONGAN, ES ;
JACOX, RF ;
VAUGHAN, JH .
ANNALS OF INTERNAL MEDICINE, 1968, 69 (04) :749-+
[8]  
CHANG C-H, 1988, Arthritis and Rheumatism, V31, pS56
[9]   PRIMATE ERYTHROCYTE-IMMUNE COMPLEX-CLEARING MECHANISM [J].
CORNACOFF, JB ;
HEBERT, LA ;
SMEAD, WL ;
VANAMAN, ME ;
BIRMINGHAM, DJ ;
WAXMAN, FJ .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (02) :236-247
[10]  
DAHA MR, 1982, CLIN EXP IMMUNOL, V48, P733